相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor-Induced Osteomalacia
Pablo Florenzano et al.
CALCIFIED TISSUE INTERNATIONAL (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Challenges in the management of tumor-induced osteomalacia (TIO)
Maria Luisa Brandi et al.
BONE (2021)
Burosumab for the Treatment of Tumor-Induced Osteomalacia
Suzanne M. Jan de Beur et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Matthew J. Page et al.
PLOS MEDICINE (2021)
Fibroblast Growth Factor Receptor 1 (FGFR1) Amplification Detected by Droplet Digital Polymerase Chain Reaction (ddPCR) Is a Prognostic Factor in Colorectal Cancers
Jeong Mo et al.
CANCER RESEARCH AND TREATMENT (2020)
Performance of 68Ga-DOTA-SST PET/CT, octreoscan SPECT/CT and 18F-FDG PET/CT in the detection of culprit tumors causing osteomalacia: a meta-analysis
Yuanyuan Jiang et al.
NUCLEAR MEDICINE COMMUNICATIONS (2020)
Tumor-induced rickets-osteomalacia: an enigma
Sandeep Kumar et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2020)
Peptide Receptor Radionuclide Therapy for a Phosphaturic Mesenchymal Tumor
Simon Hafliger et al.
CASE REPORTS IN ONCOLOGY (2020)
Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy
Clemens Bergwitz et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2019)
Tumor-induced osteomalacia: experience from three tertiary care centers in India
Rimesh Pal et al.
ENDOCRINE CONNECTIONS (2019)
Phosphaturic mesenchymal tumors: A review and update
Andrew L. Folpe
SEMINARS IN DIAGNOSTIC PATHOLOGY (2019)
Sex Differences in Cancer: Epidemiology, Genetics and Therapy
Hae-In Kim et al.
BIOMOLECULES & THERAPEUTICS (2018)
Tumour-induced osteomalacia
Salvatore Minisola et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Peptide Receptor Radionuclide and Octreotide: A Novel Approach for Metastatic Tumor-Induced Osteomalacia
Abilash Nair et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2017)
Tumor induced osteomalacia: associated with elevated circulating levels of fibroblast growth factor-7 in addition to fibroblast growth factor-23
Shweta Bansal et al.
CLINICAL NEPHROLOGY (2016)
Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour
Jen-Chieh Lee et al.
JOURNAL OF PATHOLOGY (2015)
Radiofrequency Ablation, an Effective Modality of Treatment in Tumor-Induced Osteomalacia: A Case Series of Three Patients
Swati Jadhav et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration
Maria E. Rodriguez-Ortiz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Acute exposure to high-fat diets increases hepatic expression of genes related to cell repair and remodeling in female rats
Colette N. Miller et al.
NUTRITION RESEARCH (2014)
Tumor-induced osteomalacia with normal systemic fibroblast growth factor-23 level
Ambika Amblee et al.
CLINICAL KIDNEY JOURNAL (2014)
Expression Analysis of Fibroblast Growth Factor-23, Matrix Extracellular Phosphoglycoprotein, Secreted Frizzled-Related Protein-4, and Fibroblast Growth Factor-7: Identification of Fibroblast Growth Factor-23 and Matrix Extracellular Phosphoglycoprotein as Major Factors Involved in Tumor-Induced Osteomalacia
Mouhammed Habra et al.
Endocrine Practice (2013)
Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia
Yasuo Imanishi et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2012)
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny F. Whiting et al.
ANNALS OF INTERNAL MEDICINE (2011)
Selective Venous Catheterization for the Localization of Phosphaturic Mesenchymal Tumors
Panagiota Andreopoulou et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Mechanisms of Disease: Genetic Disorders of Renal Phosphate Transport.
Dominique Prie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Ostéomalacie oncogénique : le FGF 23 ne fait pas tout
A. Tournier et al.
REVUE DE MEDECINE INTERNE (2010)
Bone Turnover and the Osteoprotegerin-RANKL Pathway in Tumor-Induced Osteomalacia: A Longitudinal Study of Five Cases
Domenico Rendina et al.
CALCIFIED TISSUE INTERNATIONAL (2009)
Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease
Jason Stubbs et al.
SEMINARS IN DIALYSIS (2007)
Cinacalcet in the management of tumor-induced osteomalacia
Jordan L. Geller et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
FGF23 is a hormone-regulating phosphate metabolism - Unique biological characteristics of FGF23
Seiji Fukumoto et al.
BONE (2007)
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
T Shimada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia
QL Huang et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2000)
分享论文
